González GJL, Menéndez NJ, Copo JJA, Abela LA

Language: Spanish
References: 18
Page: 69-75
PDF size: 274.83 Kb.

ABSTRACT

Pseudomyxoma peritonei, a disease of recurrent progression with variable malignant potential, is characterized by pressing gelatinous ascytis and frequently by generalized peritoneal invasion. During many years, it was considered as untreatable and incurable disease; however, in the last few decades, very specialized centers have focused on the radical and multimodal treatment of this disease with a view to curing it. Here is the case of a 43 years-old patient with advanced appendicealpseudomyxoma that recovered well after an aggressive treatment.

REFERENCES

1. Zapata E, Cosme A, Poch M, Fernández J, Ojeda E. Seudomixoma peritoneal. Diagnóstico mediante técnicas de imagen. Sistema. 2009;39(90).

2. O'Connell JT, Tomlinson JS, Roberts AA, McGonigle KF,Barsky SH. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol. 2002;161:551-64.

3. Lersch C, Frimberger E, Ott R, Classen M. Gray-scale sonographic findings in a patient with pseudomyxoma peritonei. J Clin Ultrasound. 2001;29:186-91

4. Farré Alegre P,Bretcha B, Martín ML, Sureda M, Brugarolas A. Carcinomatosis peritoneal. Quimioterapia intraperitoneal con hipertermia. Oncología. 2004;27(4):262-6.

5. Guerrero A, et al.Carcinomatosis peritoneal por tumor apendicular. Oncología. 2005;28(4):197-201.

6. Glehen O, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol. 2003;21(5):799-806.

7. Verwall V, van Ruth S, de Bree E, van Slooten W, van Tinteren H. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-43.

8. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann SurgOncol. 1999;6:727-31.

9. Sugarbaker PH. Epithelial appendiceal neoplasms. Cancer J. 2009;15:225-35.

10. Yan TD, Black D, Savady R, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxomaperitonei. Ann Surg Oncol. 2007;14: 484-92.

11. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxomaperitonei syndrome? Lancet Oncol. 2006;7:69-76.

12. GonzálezMoreno S. Cirugía citorreductora y quimioterapia intraperitoneal perioperatoria para las neoplasias con diseminación peritoneal: ha llegado el momento. Cir Esp. 2005;78:341-3.

13. González Moreno S, Bretcha Boix P, Rufián Peña S, Cristóbal Muñoz Casares F. Conceptos importantes sobre el tratamiento de las neoplasiasapendiculares mucinosas y del seudomixoma peritoneal. Cirugía Española. 2011;89(3):200-2.

14. Foster JM, Gupta PK, Carreau JH, Grotz TE, Blas JV, Gatalica Z, Loggie BW. Right hemicolectomy is not routinely indicated in pseudomyxoma peritonei. The American surgeon. 2012;78(2):171-7.

15. Andréasson H, Graf W, Nygren P, Glimelius B, Mahteme H. Outcome differences between debulking surgery and cytoreductive surgery in patients with pseudomyxoma peritonei. European Journal of Surgical Oncology (EJSO). 2012;38(10):962-8.

16. Cole KL, Choudry HA, Jones HL, Goodell PP, Bartlett DL. Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with Pseudomyxoma peritonei. Journal of Surgical Oncology. 2012;106(4):513-6.

17. Carr NJ, Finch J, Ilesley IC, Chandrakumaran K, Mohamed F, Mirnezami A, Moran B. Pathology and prognosis in pseudomyxomaperitonei: a review of 274 cases. Journal of Clinical Pathology. 2012;65(10):919-23.

18. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Morris DL. Early-and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Journal of Clinical Oncology. 2012;30(20):2449-56.